'For the quarter ending March 2024, consolidated Net sales (including other operating income) of Divis Laboratories has increased 18.04% to Rs 2303 crore compared to quarter ended March 2023.  Operating profit margin has jumped from 24.96% to 31.74%, leading to 50.10% rise in operating profit to Rs 731.00 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 41.82% to 38.96%.   Employee cost decreased from 13.35% to 12.89%.   Other expenses fell from 19.62% to 16.18%.   

Other income rose 19.70% to Rs 79 crore.  PBIDT rose 46.47% to Rs 810 crore.  Provision for interest remained nil.  Loan funds declined from Rs 4.00 crore as of 31 March 2023 to Rs 3.00 crore as of 31 March 2024.  Inventories rose to Rs 3,184.00 crore as of 31 March 2024 from Rs 3,000.00 crore as of 31 March 2023.  Sundry debtors were higher at Rs 2,156.00 crore as of 31 ...

• 

  (03-May-2025)

  Godrej Properties

  Net down 29% on lower OPM, higher share of loss from associates and higher taxation
• 

  (03-May-2025)

  Deep Industries

  Net in red hit by higher EO Expenses
• 

  (02-May-2025)

  Marico

  NP up 7.86%
• 

  (02-May-2025)

  Indian Overseas Bank

  Loan growth up 14%, asset quality and margin improves